A Phase II /III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum]
2018 ◽
Vol Volume 12
◽
pp. 2637-2638
Joseph Tauber
◽
Barry A Schechter
◽
Jason Bacharach
◽
Melissa M Toyos
◽
Robert Smyth-Medina
◽
...
2018 ◽
Vol Volume 12
◽
pp. 1921-1929
◽
Joseph Tauber
◽
Barry A Schechter
◽
Jason Bacharach
◽
Melissa M Toyos
◽
Robert Smyth-Medina
◽
...
2019 ◽
Vol Volume 13
◽
pp. 215-216
Joseph Tauber
◽
Barry A Schechter
◽
Jason Bacharach
◽
Melissa M Toyos
◽
Robert Smyth-Medina
◽
...
2019 ◽
Vol 126
(6)
◽
pp. 792-800
◽
David L. Wirta
◽
Gail L. Torkildsen
◽
Helen R. Moreira
◽
John D. Lonsdale
◽
Joseph B. Ciolino
◽
...
2021 ◽
Vol 6
(0)
◽
pp. 89-100
Saurabh Nigam
◽
Shalini Gupta
◽
Poonam Gupta
2021 ◽
Vol 37
(1)
◽
pp. 4-11
Jeongah Shin
◽
Chang Rae Rho
◽
Joon Young Hyon
◽
Tae-Young Chung
◽
Kyung Chul Yoon
◽
...
2019 ◽
Vol Volume 13
◽
pp. 887-894
◽
Elizabeth Yeu
◽
Damien F Goldberg
◽
Francis S Mah
◽
Kenneth A Beckman
◽
Jodi I Luchs
◽
...
2019 ◽
Vol 37
(9)
◽
pp. 527-531
◽
Rolando Toyos
◽
Melissa Toyos
◽
Jennifer Willcox
◽
Haylie Mulliniks
◽
James Hoover
2021 ◽
Vol Volume 15
◽
pp. 3983-3991
Fahmeeda Murtaza
◽
Dana Toameh
◽
Saed Al-Habib
◽
Raj Maini
◽
Hannah H Chiu
◽
...
Close
Export Citation Format
Close
Share Document
Close